Bagneux (France) and Cambridge (United Kingdom) – Genomic Vision (FR0011799907 – GV, the “Company”), a biotechnology company listed on Euronext which develops tools and services dedicated to the analysis and control of genome modifications , announces that it has selected Cambridge Consultants, a leading product development and technology consulting firm, subsidiary of Capgemini Invent, to jointly develop the next generation of a technology platform dedicated to the analysis of structural and functional changes in the genome .
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected]